Advertisement
 
  Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
    « Previous Issue | Next Issue »
  Cover Image

Volume 25, Issue 2; February 1, 2005

To see an article, click its "Full Text" or "PDF" link. To review many abstracts, check the boxes to the left of the titles you want, and click the "Get All Checked Abstract(s)" button. To see one abstract at a time, click its "Abstract" link.

button_lock_image article is free immediately upon publication

 

EditorialsBack

Exercise and the Prothrombotic State: A Paradox of Cardiovascular Prevention or an Enhanced Prothrombotic State?

Graham Thrall and Gregory Y.H. Lip
Arterioscler Thromb Vasc Biol. 2005;25:265-266, doi:10.1161/01.ATV.0000154579.11213.da
Extract | Full Text | PDF  

Apolipoprotein E and Atherosclerosis: Beyond Lipid Effect

Jean Davignon
Arterioscler Thromb Vasc Biol. 2005;25:267-269, doi:10.1161/01.ATV.0000154570.50696.2c
Extract | Full Text | PDF  

Are Circulating CD133+ Cells Biomarkers of Vascular Disease?

Gina Schatteman
Arterioscler Thromb Vasc Biol. 2005;25:270-271, doi:10.1161/01.ATV.0000154484.58485.24
Extract | Full Text | PDF  

 

Brief ReviewsBack

ATVB In Focus: Redox Mechanisms in Blood Vessels

Kathy K. Griendling
Arterioscler Thromb Vasc Biol. 2005;25:272-273, doi:10.1161/01.ATV.0000153515.72375.3b
Extract | Full Text | PDF  

Cornelius F.H. Mueller, Karine Laude, J. Scott McNally, and David G. Harrison
Arterioscler Thromb Vasc Biol. 2005;25:274-278; published online before print October 28 2004, doi:10.1161/01.ATV.0000149143.04821.eb
Abstract | Full Text | PDF
Reactive oxygen species have been implicated in the pathogenesis of virtually every stage of vascular lesion formation, hypertension, and other vascular diseases. Upcoming series of articles in Arteriosclerosis, Thrombosis, and Vascular Biology help elucidate how reactive oxygen species are produced by vascular cells and their role in vascular homeostasis.  

Jason D. Morrow
Arterioscler Thromb Vasc Biol. 2005;25:279-286; published online before print December 9 2004, doi:10.1161/01.ATV.0000152605.64964.c0
Abstract | Full Text | PDF
Enhanced oxidant stress occurring either locally in the vessel wall or systemically is implicated in the pathogenesis of atherosclerosis in humans. Nonetheless, evidence that oxidant stress is increased in vivo in association with this disease and that it can be quantified in living human beings has been lacking. Recently, the development of methods to quantify the F2-isoprostanes (IsoPs) has allowed a facile and accurate assessment of oxidant stress in vivo. The purpose of this brief review is to discuss the usefulness of quantifying IsoPs as an index of oxidative injury in association with atherosclerosis.  

Anetta Undas, Kathleen E. Brummel-Ziedins, and Kenneth G. Mann
Arterioscler Thromb Vasc Biol. 2005;25:287-294; published online before print November 29 2004, doi:10.1161/01.ATV.0000151647.14923.ec
Abstract | Full Text | PDF
The HMG-CoA reductase inhibitors (statins) have been shown to exhibit several vascular protective effects, including antithrombotic properties, that are not related to changes in lipid profile. Treatment with statins can lead to a significant downregulation of the blood coagulation cascade, most probably as a result of decreased tissue factor expression, which leads to reduced thrombin generation.  

 

Vascular BiologyBack

R. Dwivedi, S. Saha, P.J. Chowienczyk, and J.M. Ritter
Arterioscler Thromb Vasc Biol. 2005;25:e7-e9; published online before print December 9 2004, doi:10.1161/01.ATV.0000152610.40086.31
Abstract | Full Text | PDF
The possible involvement of inward-rectifying K+ channels (KIR) in the action of bradykinin was investigated by administering drugs via the brachial artery in healthy men. Barium selectively inhibited the forearm blood flow response to bradykinin, indicating that a component of this response is mediated by KIR.  

Tiffany M. Powell, Jonathan D. Paul, Jonathan M. Hill, Michael Thompson, Moshe Benjamin, Maria Rodrigo, J. Philip McCoy, Elizabeth J. Read, Hanh M. Khuu, Susan F. Leitman, Toren Finkel, and Richard O. Cannon, III
Arterioscler Thromb Vasc Biol. 2005;25:296-301; published online before print November 29 2004, doi:10.1161/01.ATV.0000151690.43777.e4
Abstract | Full Text | PDF
Endothelial progenitor cells (EPCs) are reduced in coronary artery disease. Granulocyte colony-stimulating factor (CSF) administered to patients increased: (1) CD133+/VEGFR-2+ cells consistent with EPC phenotype; (2) CD133+ cells coexpressing the chemokine receptor CXCR4, important for homing of EPCs to ischemic tissue; and (3) endothelial cell-forming clusters in culture. Whether EPCs mobilized into the circulation will be useful for the purpose of initiating vascular growth and myocyte repair in coronary artery disease patients must be tested in clinical trials.  

Raymond Tabibiazar, Roger A. Wagner, Joshua M. Spin, Euan A. Ashley, Balasubramanian Narasimhan, Edward M. Rubin, Bradley Efron, Phil S. Tsao, Robert Tibshirani, and Thomas Quertermous
Arterioscler Thromb Vasc Biol. 2005;25:302-308; published online before print November 18 2004, doi:10.1161/01.ATV.0000151372.86863.a5
Abstract | Full Text | PDF | Data Supplement
To gain insights into the molecular pathways that are differentially activated in strains of mice with varied susceptibility to atherosclerosis, we performed comprehensive transcriptional profiling of their vascular wall. Genes identified through these studies expand the repertoire of factors in disease-related signaling pathways and identify novel candidate genes in atherosclerosis.  

John J. Lepore, Thomas P. Cappola, Patricia A. Mericko, Edward E. Morrisey, and Michael S. Parmacek
Arterioscler Thromb Vasc Biol. 2005;25:309-314; published online before print December 9 2004, doi:10.1161/01.ATV.0000152725.76020.3c
Abstract | Full Text | PDF | Data Supplement
An unbiased microarray screen of genes regulated by GATA-6 in VSMCs identified multiple genes involved in cell-cell signaling and cell-matrix interactions. The endothelin-1 and the AT1a receptor genes were shown to be direct GATA-6 target genes. These data suggest that GATA-6 plays a role in promoting synthetic functions in VSMCs.  

Barbara Pini, Tilo Grosser, John A. Lawson, Tom S. Price, Michael A. Pack, and Garret A. FitzGerald
Arterioscler Thromb Vasc Biol. 2005;25:315-320; published online before print December 2 2004, doi:10.1161/01.ATV.0000152355.97808.10
Abstract | Full Text | PDF | Data Supplement
Mircosomal prostaglandin E synthase (mPGES)-1, located downstream of COX-2, may represent a novel antiinflammatory drug target. Zebrafish cytosolic (c) PGES-1 and COX-1 were coordinately expressed; mPGES-1 and COX-2 were expressed particularly in the vasculature. Zebrafish may afford a high throughput system for detection of novel PGES inhibitors.  

U. Ruth Michaelis, John R. Falck, Ronald Schmidt, Rudi Busse, and Ingrid Fleming
Arterioscler Thromb Vasc Biol. 2005;25:321-326; published online before print November 29 2004, doi:10.1161/01.ATV.0000151648.58516.eb
Abstract | Full Text | PDF | Data Supplement
Overexpression of cytochrome P450 (CYP) 2C9 in endothelial cells increased cAMP levels, stimulated the cAMP-response element-binding protein, and enhanced cyclooxygenase-2 (COX-2) promoter activity, protein expression, and prostacyclin production. CYP2C9 overexpression stimulated endothelial tube formation, which was attenuated by the COX-2 inhibitor celecoxib. Thus, COX-2 contributes to CYP2C9-induced angiogenesis.  

Kenichi Sakamoto, Takahisa Murata, Hiroko Chuma, Masatoshi Hori, and Hiroshi Ozaki
Arterioscler Thromb Vasc Biol. 2005;25:327-333; published online before print December 9 2004, doi:10.1161/01.ATV.0000152611.50953.e2
Abstract | Full Text | PDF
We examined the inhibitory mechanisms of fluvastatin on FBS-induced vascular hypertrophy assessed by organ-cultured artery. Results suggest that fluvastatin inhibits vascular smooth muscle phenotype modulation and proliferation by inhibiting the ERK1/2 and p38MAPK activities through depletion of mevalonate in smooth muscle cells, resulting in inhibiting vascular hyperplastic changes.  

Shing-Jong Lin, Song-Kun Shyue, Ya-Yun Hung, Yung-Hsiang Chen, Hung-Hai Ku, Jaw-Wen Chen, Ka-Bik Tam, and Yuh-Lien Chen
Arterioscler Thromb Vasc Biol. 2005;25:334-340; published online before print December 2 2004, doi:10.1161/01.ATV.0000152114.00114.d8
Abstract | Full Text | PDF | Data Supplement
Superoxide dismutase overexpression in endothelial cells attenuates tumor necrosis factor-{alpha}-induced superoxide anion production and adhesion molecule expression, and this effect is mediated by decreased JNK and p38 phosphorylation and AP-1 and nuclear factor {kappa}B inactivation. These results suggest that superoxide dismutase may play an important role in the prevention of atherosclerosis and inflammatory response.  

Mahito Sato, Keiko Kawai-Kowase, Hiroko Sato, Yuko Oyama, Hiroyoshi Kanai, Yoshio Ohyama, Tatsuo Suga, Toshitaka Maeno, Yasuhiro Aoki, Junichi Tamura, Hironosuke Sakamoto, Ryozo Nagai, and Masahiko Kurabayashi
Arterioscler Thromb Vasc Biol. 2005;25:341-347; published online before print December 9 2004, doi:10.1161/01.ATV.0000152608.29351.8f
Abstract | Full Text | PDF | Data Supplement
TGF-ß1 controls the expression of numerous genes, including SM22{alpha} and PAI-1. We investigated whether c-Src plays a role in TGF-ß1 signaling. TGF-ß1 induction of such genes was significantly reduced in Src family tyrosine kinase-deficient cells, and Csk and pharmacological inhibitors for Src family kinases or antioxidants inhibit the effects of TGF-ß1. These results indicate that c-Src and hydrogen peroxide are required for TGF-ß1 signaling.  

Augusto Orlandi, Sabina Pucci, Alessandro Ciucci, Flavia Pichiorri, Amedeo Ferlosio, and Luigi Giusto Spagnoli
Arterioscler Thromb Vasc Biol. 2005;25:348-353; published online before print December 9 2004, doi:10.1161/01.ATV.0000152609.28569.e1
Abstract | Full Text | PDF | Data Supplement
Clusterin was detected in human arterial myointimal thickening and absent in the underlying media. Rat neointimal cells overexpressed clusterin and clusterin antisense oligonucleotide reduced proliferation and increased apoptosis. All-trans retinoic acid-induced proliferative arrest showed association with s-CLU reduction and n-CLU overexpression with apoptosis, supporting a different biological role of these isoforms.  

Jianhua Huang, Xi-Lin Niu, Anne M. Pippen, Brian H. Annex, and Christopher D. Kontos
Arterioscler Thromb Vasc Biol. 2005;25:354-358; published online before print November 29 2004, doi:10.1161/01.ATV.0000151619.54108.a5
Abstract | Full Text | PDF
Phosphoinositide (PI) 3-kinase is a critical regulator of neointimal hyperplasia. The inositol 3-phosphatase PTEN modulates PI 3-kinase signaling by hydrolyzing the phospholipid products of PI 3-kinase, and overexpression of PTEN in vascular smooth muscle cells inhibits the cellular processes necessary for neointimal hyperplasia. The effects of adenovirus-mediated PTEN (AdPTEN) overexpression on neointimal hyperplasia were tested in the rat carotid injury model. Compared with control arteries, AdPTEN treatment significantly reduced neointimal area and percent stenosis by enhancing medial cell apoptosis and inhibiting proliferation of the remaining viable cells. Thus, PTEN provides a new target for the treatment of neointimal hyperplasia.  

Ouafa Rebaï, Josette Le Petit-Thevenin, Nadine Bruneau, Dominique Lombardo, and Alain Vérine
Arterioscler Thromb Vasc Biol. 2005;25:359-364; published online before print November 29 2004, doi:10.1161/01.ATV.0000151618.49109.bd
Abstract | Full Text | PDF | Data Supplement
We delineate the in vitro effects of pancreatic BSDL on endothelial cells, and we show that BSDL promotes proliferation, migration, capillary network formation, and wound-healing of HUVECs via the displacement of bFGF and VEGF from the ECM, suggesting that BSDL could be involved in angiogenesis.  

Alec D. Weisberg, Francisco Albornoz, Jane P. Griffin, David L. Crandall, Hassan Elokdah, Agnes B. Fogo, Douglas E. Vaughan, and Nancy J. Brown
Arterioscler Thromb Vasc Biol. 2005;25:365-371; published online before print December 2 2004, doi:10.1161/01.ATV.0000152356.85791.52
Abstract | Full Text | PDF | Data Supplement
In this study, the effect of pharmacological PAI-1 inhibition in a mouse model of Ang II-induced vascular remodeling and cardiac fibrosis was examined. PAI-1 inhibition significantly attenuated Ang II-induced aortic medial and wall thickening, but not cardiac hypertrophy, and enhanced Ang II/salt-induced cardiac fibrosis.  

Yasmin, Sharon Wallace, Carmel M. McEniery, Zahid Dakham, Pawan Pusalkar, Kaisa Maki-Petaja, Mike J. Ashby, John R. Cockcroft, and Ian B. Wilkinson
Arterioscler Thromb Vasc Biol. 2005;25:372-378; published online before print November 18 2004, doi:10.1161/01.ATV.0000151373.33830.41
Abstract | Full Text | PDF
The relationship between arterial stiffness and elastase activity was examined in isolated systolic hypertension (ISH), and separately in a large cohort of healthy individuals. Aortic stiffness is related to MMP-9, not only in ISH, but also in healthy individuals, suggesting elastases may be involved in the process of arterial stiffening and the development of ISH.  

Pål I. Holm, Per M. Ueland, Stein Emil Vollset, Øivind Midttun, Henk J. Blom, Miranda B.A.J. Keijzer, and Martin den Heijer
Arterioscler Thromb Vasc Biol. 2005;25:379-385; published online before print November 18 2004, doi:10.1161/01.ATV.0000151283.33976.e6
Abstract | Full Text | PDF | Data Supplement
In 500 healthy subjects, postmethionine load increase in tHcy showed a stronger inverse relation to betaine than to folate and vitamin B6, whereas for fasting tHcy, betaine was a weaker determinant than folate. For both tHcy modalities, the association with betaine was most pronounced in subjects with low folate status.  

 

Atherosclerosis and LipoproteinsBack

Rolf Mitusch, Jan Luedemann, William G. Wood, Klaus Berger, Ulf Schminke, Matthias Suter, Christof Kessler, Ulrich John, Jan Rupp, Michael Kentsch, and Matthias Maass
Arterioscler Thromb Vasc Biol. 2005;25:386-391; published online before print November 18 2004, doi:10.1161/01.ATV.0000151284.49967.a7
Abstract | Full Text | PDF
C pneumoniae has been implicated in atherogenesis. We determined the association of chlamydial DNA in peripheral blood mononuclear cells with the carotid intima-media thickness from 1032 healthy subjects from a general population survey. A stratified group interaction analysis revealed an independent association in normotensive subjects and those <70 years old.  

Markus Juonala, Jorma S.A. Viikari, Mika Kähönen, Leena Taittonen, Tapani Rönnemaa, Tomi Laitinen, Noora Mäki-Torkko, Vera Mikkilä, Leena Räsänen, Hans K. Åkerblom, Erkki Pesonen, and Olli T. Raitakari
Arterioscler Thromb Vasc Biol. 2005;25:392-398; published online before print November 11 2004, doi:10.1161/01.ATV.0000150042.43866.7f
Abstract | Full Text | PDF | Data Supplement
We studied whether an east-west difference exists in markers of subclinical atherosclerosis in 2264 Finns aged 24 to 39 years. Subjects with family origin in eastern Finland had greater carotid IMT and lower brachial FMD compared with western subjects, suggesting that hereditable factors play a role in excess atherosclerosis risk in eastern Finland.  

James H. Stein, Michelle A. Merwood, Jennifer B. Bellehumeur, Patrick E. McBride, Donald A. Wiebe, and James M. Sosman
Arterioscler Thromb Vasc Biol. 2005;25:399-405; published online before print December 2 2004, doi:10.1161/01.ATV.0000152233.80082.9c
Abstract | Full Text | PDF
An oral fat load was administered to 55 HIV-positive and 10 HIV-negative individuals. Postprandial clearance of triglyceride-rich lipoproteins was delayed in HIV-positive individuals. Compared with HIV-positive subjects not on PIs, those taking PIs do not have increased postprandial triglyceride-rich lipoproteins but do have increased postprandial intermediate-density and low-density lipoproteins.  

C. Giannattasio, A. Zoppo, G. Gentile, M. Failla, A. Capra, F.M. Maggi, A. Catapano, and G. Mancia
Arterioscler Thromb Vasc Biol. 2005;25:406-410; published online before print December 2 2004, doi:10.1161/01.ATV.0000152231.93590.17
Abstract | Full Text | PDF
An oral fat load was administered to 55 HIV-positive and 10 HIV-negative individuals. Postprandial clearance of triglyceride-rich lipoproteins was delayed in HIV-positive individuals. Compared with HIV-positive subjects not on PIs, those taking PIs do not have increased postprandial triglyceride-rich lipoproteins but do have increased postprandial intermediate-density and low-density lipoproteins.Hypercholesterolemia impairs endothelial function, whereas the effect of hypertriglyceridemia is less clear. In normotensive subjects with an untreated hypertriglyceridemia and hypercholesterolemia, we measured endothelial function before and 6 hours after a high-fat meal. The results demonstrate that in moderately dyslipidemic patients, endothelial function is impaired by acute hypertriglyceridemia.  

Claudio Priore Oliva, Livia Pisciotta, Giovanni Li Volti, Maria Paola Sambataro, Alfredo Cantafora, Antonella Bellocchio, Alberico Catapano, Patrizia Tarugi, Stefano Bertolini, and Sebastiano Calandra
Arterioscler Thromb Vasc Biol. 2005;25:411-417; published online before print December 9 2004, doi:10.1161/01.ATV.0000153087.36428.dd
Abstract | Full Text | PDF
Mutations in APOA5 gene might be the cause of severe hypertriglyceridemia in subjects in whom mutations in LPL or APOC2 genes have been excluded. We detected a nonsense mutation in APOA5 gene (Q145X) in a boy with hyperchylomicronemia syndrome. This is the first observation of a complete apoA-V deficiency in humans.  

Theodosios Kyriakou, Conrad Hodgkinson, David E. Pontefract, Srikanth Iyengar, W. Martin Howell, Yuk-ki Wong, Per Eriksson, and Shu Ye
Arterioscler Thromb Vasc Biol. 2005;25:418-423; published online before print November 4 2004, doi:10.1161/01.ATV.0000149379.72018.20
Abstract | Full Text | PDF
The study showed that the ABCA1 gene -565C>T polymorphism was associated with severity of coronary atherosclerosis in a cohort of patients from Southern England and that this sequence variant per se had an effect on promoter activity of the ABCA1 gene. The data support the notion that common ABCA1 gene variants can contribute to interindividual variability in atherosclerosis susceptibility and severity.  

Akio Kawakami, Mariko Tani, Tsuyoshi Chiba, Katsumasa Yui, Shohei Shinozaki, Katsuyuki Nakajima, Akira Tanaka, Kentaro Shimokado, and Masayuki Yoshida
Arterioscler Thromb Vasc Biol. 2005;25:424-429; published online before print December 9 2004, doi:10.1161/01.ATV.0000152632.48937.2d
Abstract | Full Text | PDF | Data Supplement
RLPs induced macrophage foam cell formation via apoB48R. Pitavastatin inhibited RLP-induced macrophage foam cell formation, at least in part, via inhibition of apoB48R expression. Our findings indicate a potential role of apoB48R in atherosclerosis.  

Yoshitaka Murata, Akihide Tanimoto, Ke-Yong Wang, Masato Tsutsui, Yasuyuki Sasaguri, Filip De Corte, and Hiroshi Matsushita
Arterioscler Thromb Vasc Biol. 2005;25:430-435; published online before print October 28 2004, doi:10.1161/01.ATV.0000148705.13411.65
Abstract | Full Text | PDF | Data Supplement
The presence of histamine-producing macrophages and gene expression of histamine receptors and GM-CSF was demonstrated in arteriosclerotic lesions. In monocytic U937 cells, GM-CSF upregulated the expression of histamine and HH1R. Coordinated expression of histamine and its receptors by GM-CSF would participate in atherogenesis by affecting monocytic and SMC gene expression.  

Robert L. Raffai, Samuel M. Loeb, and Karl H. Weisgraber
Arterioscler Thromb Vasc Biol. 2005;25:436-441; published online before print December 9 2004, doi:10.1161/01.ATV.0000152613.83243.12
Abstract | Full Text | PDF
Using Apoeh/hMx1-Cre mice we have begun to address apolipoprotein E-mediated mechanisms of atherosclerosis regression. We report the existence of a cholesterol-independent role of apolipoprotein E in atherosclerosis regression. This mechanism is critical for lipid removal from the fibrotic component of the plaque but not from the foam cell-rich layer beneath the endothelium.  

Keiichi Hishikawa, Toshio Nakaki, and Toshiro Fujita
Arterioscler Thromb Vasc Biol. 2005;25:442-446; published online before print October 21 2004, doi:10.1161/01.ATV.0000148404.24271.fc
Abstract | Full Text | PDF
In apoE-/- mice, oral caffeic acid phenethyl ester (CAPE) supplementation attenuates the atherosclerotic process and reduces NF-{kappa}B activity and expression of NF-{kappa}B-related genes in the aorta. This may be attributable to direct inhibition of NF-{kappa}B in the lesion and reduction of systemic oxidative stress.  

Joerg Herrmann, Saquib Samee, Alejandro Chade, Martin Rodriguez Porcel, Lilach O. Lerman, and Amir Lerman
Arterioscler Thromb Vasc Biol. 2005;25:447-453; published online before print December 9 2004, doi:10.1161/01.ATV.0000152606.34120.97
Abstract | Full Text | PDF | Data Supplement
Intima-media remodeling is well-described in coronary artery disease in contrast to adventitial remodeling. Results of the current study on coronary arteries of pigs, randomized to 12 weeks of normal diet (N), hypercholesterolemic diet (HC), or renovascular hypertensive (HT), indicate that adventitial remodeling precedes intima-media remodeling early after risk factor exposure with distinct qualitative differences.  

 

ThrombosisBack

Jong-Shyan Wang, Yu-San Li, Jin-Chung Chen, and Yu-Wen Chen
Arterioscler Thromb Vasc Biol. 2005;25:454-460; published online before print November 29 2004, doi:10.1161/01.ATV.0000151987.04607.24
Abstract | Full Text | PDF | Data Supplement
This investigation shows that exercise training decreases resting and severe exercise-promoted platelet aggregation induced by alternating shear stress (ASIPA); moreover, this effect is accompanied by reduced the von Willebrand factor binding and P-selectin expression on platelets. However, the effects of training on ASIPA are reversed to the pretraining state after deconditioning.  

Gabi Busch, Isabell Seitz, Birgit Steppich, Sibylle Hess, Robert Eckl, Albert Schömig, and Ilka Ott
Arterioscler Thromb Vasc Biol. 2005;25:461-466; published online before print November 18 2004, doi:10.1161/01.ATV.0000151279.35780.2d
Abstract | Full Text | PDF | Data Supplement
This study investigates the relationship between the activation of coagulation and systemic inflammatory changes in acute myocardial infarction. Tissue factor pathway inhibitor factor Xa but not F1+2 plasma levels were associated with circulating interleukin-8. In vitro factor Xa stimulated interleukin-8 and monocyte chemoattractant protein-1 release and RNA expression by activation of protease-activated receptors-1 as an underlying mechanism.  

Gyula Remenyi, Robert Szasz, Paul Friese, and George L. Dale
Arterioscler Thromb Vasc Biol. 2005;25:467-471; published online before print December 9 2004, doi:10.1161/01.ATV.0000152726.49229.bf
Abstract | Full Text | PDF
Formation of coated-platelets involves a complex set of activation events initiated by dual agonist activation. The mitochondrial permeability transition pore (MPTP) is a key intermediate in apoptosis and has been suggested to impact platelet activation. This report demonstrates that MPTP formation is essential to production of coated-platelets.  

 

CorrectionsBack

Correction


Arterioscler Thromb Vasc Biol. 2005;25:472, doi:10.1161/01.ATV.0000157494.59480.2e
Extract | Full Text | PDF  

Spotlight

TOC Spotlight File Banner1TOCpage

Banner2TOCpage